Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
Aging is associated with alterations in the intestinal microbiota and with immunosenescence. Probiotics have the potential to modify a selected part of the intestinal microbiota as well as improve immune functions and may, therefore, be particularly beneficial to elderly consumers. In this randomized, controlled cross-over clinical trial, we assessed the effects of a probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM on the intestinal microbiota and fecal immune markers of 31 elderly volunteers and compared these effects with the administration of the same cheese without probiotics. The probiotic cheese was found to increase the number of L. rhamnosus and L. acidophilus NCFM in the feces, suggesting the survival of the strains during the gastrointestinal transit. Importantly, probiotic cheese administration was associated with a trend towards lower counts of Clostridium difficile in the elderly, as compared with the run-in period with the plain cheese. The effect was statistically significant in the subpopulation of the elderly who harbored C. difficile at the start of the study. The probiotic cheese was not found to significantly alter the levels of the major microbial groups, suggesting that the microbial changes conferred by the probiotic cheese were limited to specific bacterial groups. Despite that the administration of the probiotic cheese to the study population has earlier been shown to significantly improve the innate immunity of the elders, we did not observe measurable changes in the fecal immune IgA concentrations. No increase in fecal calprotectin and β-defensin concentrations suggests that the probiotic treatment did not affect intestinal inflammatory markers. In conclusion, the administration of probiotic cheese containing L. rhamnosus HN001 and L. acidophilus NCFM, was associated with specific changes in the intestinal microbiota, mainly affecting specific subpopulations of intestinal lactobacilli and C. difficile, but did not have significant effects on the major microbial groups or the fecal immune markers.
Danisco Bioactives, Health & Nutrition, Sokeritehtaantie 20, 02460, Kantvik, Finland. sampo.lahtinen@danisco.com
Sampo J
SJ
Lahtinen
Sofia
S
Forssten
Juhani
J
Aakko
Linda
L
Granlund
Nina
N
Rautonen
Seppo
S
Salminen
Matti
M
Viitanen
Arthur C
AC
Ouwehand
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D002611:Cheese / Q000382:microbiology*; D016360:Clostridioides difficile / Q000302:isolation & purification*; D015169:Colony Count, Microbial; D003258:Consumer Behavior; D018592:Cross-Over Studies; D005243:Feces / Q000382:microbiology*; D006801:Humans; D007422:Intestines / Q000276:immunology / Q000382:microbiology*; D007778:Lactobacillus / Q000302:isolation & purification; D007779:Lactobacillus acidophilus; D052201:Lacticaseibacillus rhamnosus; D019936:Probiotics; D016896:Treatment Outcome
Trends Immunol. 2009 Jul;30(7):334-43
19540811
J Appl Microbiol. 2002;93(5):900-6
12392539
Trends Immunol. 2009 Jul;30(7):325-33
19541535
Am J Clin Nutr. 2008 Mar;87(3):534-8
18326589
Int Microbiol. 2004 Mar;7(1):59-62
15179608
Int J Food Microbiol. 2004 Dec 15;97(2):197-207
15541806
FEMS Immunol Med Microbiol. 2008 Jun;53(1):18-25
18336547
Br J Nutr. 2009 Feb;101(3):367-75
18634707
QJM. 2002 Sep;95(9):557-8
12205332
Immunopharmacol Immunotoxicol. 2006;28(4):665-81
17190742
Appl Environ Microbiol. 2004 Jun;70(6):3575-81
15184159
PLoS One. 2010 May 17;5(5):e10667
20498852
J Pediatr Gastroenterol Nutr. 2009 Jan;48(1):117-20
19172136
Appl Environ Microbiol. 2004 Nov;70(11):6459-65
15528506
Br J Nutr. 2004 Jun;91(6):905-14
15182394
FEMS Immunol Med Microbiol. 2010 Jun 1;59(1):53-9
20236323
J Appl Microbiol. 2004;97(6):1166-77
15546407
Appl Environ Microbiol. 2005 Dec;71(12):8344-51
16332821
Br J Nutr. 2008 Jul;100(1):130-7
18279548
Age (Dordr). 2009 Mar;31(1):59-66
19234769
Infect Control Hosp Epidemiol. 2002 Nov;23(11):696-703
12452300
Appl Environ Microbiol. 2000 Jun;66(6):2578-88
10831441
Mech Ageing Dev. 2007 Jan;128(1):92-105
17116321
Appl Environ Microbiol. 2004 Oct;70(10):6113-22
15466557
Am J Clin Nutr. 2001 Dec;74(6):833-9
11722966
J Med Microbiol. 2002 May;51(5):448-454
11990498
Science. 2005 Jun 10;308(5728):1635-8
15831718
Gut. 2001 Feb;48(2):198-205
11156640
Int J Food Microbiol. 2001 Aug 5;67(3):207-16
11518430
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4586-91
20571116
J Appl Microbiol. 2002;93(5):907-12
12392540
Appl Environ Microbiol. 2008 Mar;74(5):1646-8
18083887
Appl Environ Microbiol. 2006 Feb;72(2):1027-33
16461645